Table 3.
Rare allele frequency | To age 50 | To age 70 | |||||||
Polymorphism* | N** | RR | 95% CI | p-value | N** | RR | 95% CI | p-value | |
Base excision repair genes | |||||||||
XRCC1 R194W | 0.06 | ||||||||
RR | 51 | 1.0 | --- | 125 | 1.0 | --- | |||
RW or WW | 6 | 1.4 | 0.4–4.2 | 0.408 | 22 | 2.3 | 1.3–3.8 | 0.004 | |
XRCC1 R280H | 0.03 | ||||||||
RR | 52 | 1.0 | --- | 134 | 1.0 | --- | |||
RH or HH | 5 | 0.7 | 0.0–2.4 | 0.736 | 13 | 1.2 | 0.5–2.5 | 0.522 | |
XRCC1 R399Q | 0.37 | ||||||||
RR | 21 | 1.0 | --- | 59 | 1.0 | --- | |||
RQ | 22 | 0.7 | 0.1–2.0 | 0.444 | 64 | 1.1 | 0.4–1.6 | 0.636 | |
14 | 3.4 | 1.3–9.3 | 0.014 | 24 | 1.9 | 1.1–3.9 | 0.010 | ||
APEX Q51H | 0.04 | ||||||||
49 | 1.0 | --- | 134 | 1.0 | --- | ||||
QH or HH | 7 | 3.0 | 0.5–6.7 | 0.216 | 12 | 1.7 | 0.7–3.1 | 0.236 | |
APEX D148E | 0.49 | ||||||||
DD | 20 | 1.0 | --- | 49 | 1.0 | --- | |||
DE | 27 | 0.2 | 0.1–0.8 | 0.028 | 65 | 0.2 | 0.1–0.5 | <0.001 | |
EE | 9 | 0.8 | 0.2–1.9 | 0.546 | 32 | 1.0 | 0.6–1.7 | 0.860 | |
POLD1 R119H | 0.06 | ||||||||
RR | 44 | 1.0 | --- | 123 | 1.0 | --- | |||
RH or HH | 13 | 2.5 | 0.8–5.0 | 0.106 | 24 | 1.8 | 1.0–2.9 | 0.058 | |
BRCA1 interacting proteins | |||||||||
BRCA2 N289H | 0.03 | ||||||||
MM | 57 | 1.0 | --- | 141 | 1.0 | --- | |||
NH or HH | 0 | 0 | --- | ---- | 6 | 1.6 | 0.5–2.9 | 0.370 | |
BRCA2 N372H | 0.32 | ||||||||
NN | 30 | 1.0 | --- | 89 | 1.0 | --- | |||
NH | 23 | 0.4 | 0.1–1.3 | 0.140 | 42 | 0.2 | 0.1–0.5 | <0.001 | |
HH | 4 | 1.5 | 0.4–4.4 | 0.322 | 16 | 1.3 | 0.8–2.4 | 0.232 | |
BRCA2 T1915M | 0.05 | ||||||||
TT | 53 | 1.0 | --- | 139 | 1.0 | --- | |||
TM or MM | 4 | 1.7 | 0.0–4.0 | 0.664 | 8 | 2.1 | 0.6–3.6 | 0.215 | |
BRIP1 -64 G>A | 0.46 | ||||||||
GG | 17 | 1.0 | --- | 42 | 1.0 | --- | |||
GA | 24 | 0.4 | 0.1–1.2 | 0.126 | 70 | 0.7 | 0.2–1.2 | 0.112 | |
AA | 16 | 1.5 | 0.5–4.3 | 0.424 | 35 | 1.6 | 0.8–2.8 | 0.218 | |
BRIP1 P919S | 0.43 | ||||||||
PP | 10 | 1.0 | --- | 52 | 1.0 | --- | |||
PS | 34 | 4.5 | 0.8–12.2 | 0.096 | 69 | 0.6 | 0.3–1.2 | 0.134 | |
SS | 12 | 6.9 | 1.6–29.3 | 0.018 | 25 | 1.3 | 0.8–2.8 | 0.220 | |
ZBRK1 L66P | 0.15 | ||||||||
LL | 43 | 1.0 | --- | 108 | 1.0 | --- | |||
LP or PP | 14 | 0.9 | 0.3–2.0 | 0.712 | 38 | 1.2 | 0.7–1.9 | 0.304 | |
ZBRK1 S472P | 0.12 | ||||||||
SS | 55 | 1.0 | --- | 137 | 1.0 | --- | |||
SP or PP | 2 | 0.8 | 0.0–2.2 | 0.614 | 10 | 1.6 | 0.6–2.9 | 0.312 | |
ZBRK1 R501S | 0.12 | ||||||||
RR | 46 | 1.0 | --- | 116 | 1.0 | --- | |||
RS or SS | 11 | 0.8 | 0.2–1.8 | 0.534 | 31 | 1.2 | 0.7–2.1 | 0.434 | |
ZBRK1 1845 C>T | 0.06 | ||||||||
CC | 45 | 1.0 | --- | 121 | 1.0 | --- | |||
CT or TT | 12 | 2.2 | 0.5–4.3 | 0.218 | 25 | 1.6 | 0.8–2.8 | 0.162 | |
Growth factor genes | |||||||||
TGFß1 L10P | 0.38 | ||||||||
LL | 25 | 1.0 | --- | 54 | 1.0 | --- | |||
LP or PP | 31 | 0.5 | 0.2–1.2 | 0.148 | 92 | 0.8 | 0.5–1.5 | 0.536 | |
TGFß1 P25R | 0.10 | ||||||||
PP | 48 | 1.0 | --- | 126 | 1.0 | --- | |||
PR or RR | 8 | 1.0 | 0.1–3.1 | 0.952 | 20 | 1.2 | 0.6–2.1 | 0.554 | |
TGFß1 T263I | 0.04 | ||||||||
TT | 54 | 1.0 | --- | 138 | 1.0 | --- | |||
TI or II | 3 | 2.1 | 0.0–4.9 | 0.492 | 9 | 1.7 | 0.6–3.1 | 0.312 | |
IGFBP3 -202 A>C | 0.53*** | ||||||||
AA | 11 | 1.0 | --- | 36 | 1.0 | --- | |||
AC or CC | 45 | 1.0 | 0.3–3.5 | 0.848 | 110 | 0.7 | 0.4–1.3 | 0.228 |
* Amino acids and their symbols: R: Arginine, W: Tryptophan, H: Histidine, Q: Glutamine, D: Aspartic Acid, E: Glutamic Acid, N: Asparagine, P: Proline, S: Serine, L: Leucine, I: Isoleucine, T: Threonine. ** Numbers represent those first degree female relatives who had breast cancer up to age 50 or 70 by the genotype of the case (index proband). The numbers are not the probabilistic assignment of the kin-cohort calculation to a specific genotype. *** Represents the frequency of the C allele, although not technically "rare".